Skoog L - Search Results

1

Steroid receptor levels in breast cancer. Relationships with age and menopausal status.

Wilking N, Rutqvist LE, Nordenskjöld B, Skoog L. Wilking N, et al. Among authors: skoog l. Acta Oncol. 1989;28(6):807-10. doi: 10.3109/02841868909092312. Acta Oncol. 1989. PMID: 2611034

2

Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment.

Skoog L, Rutqvist LE, Wilking N. Skoog L, et al. Acta Oncol. 1992;31(2):139-41. doi: 10.3109/02841869209088893. Acta Oncol. 1992. PMID: 1622628

3

Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Stockholm Breast Cancer Study Group.

Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, Somell A, Theve T, Wilking N, Askergren J, et al. Rutqvist LE, et al. Among authors: skoog l. Acta Oncol. 1992;31(2):265-70. doi: 10.3109/02841869209088913. Acta Oncol. 1992. PMID: 1622644 Clinical Trial.

4

Immunocytochemical analysis of receptors for estrogen and progesterone in fine needle aspirates from anal epidermoid carcinoma.

Goldman S, Skoog L, Wilking N. Goldman S, et al. Among authors: skoog l. Dis Colon Rectum. 1992 Feb;35(2):163-5. doi: 10.1007/BF02050672. Dis Colon Rectum. 1992. PMID: 1735318

5

Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.

Rutqvist LE, Cedermark B, Glas U, Mattsson A, Skoog L, Somell A, Theve T, Wilking N, Askergren J, Hjalmar ML, et al. Rutqvist LE, et al. Among authors: skoog l. J Natl Cancer Inst. 1991 Sep 18;83(18):1299-306. doi: 10.1093/jnci/83.18.1299. J Natl Cancer Inst. 1991. PMID: 1886157 Clinical Trial.

6

The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.

Rutqvist LE, Cedermark B, Fornander T, Glas U, Johansson H, Nordenskjöld B, Rotstein S, Skoog L, Somell A, Theve T, et al. Rutqvist LE, et al. Among authors: skoog l. J Clin Oncol. 1989 Oct;7(10):1474-84. doi: 10.1200/JCO.1989.7.10.1474. J Clin Oncol. 1989. PMID: 2674335 Clinical Trial.

7

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

Stål O, Wingren S, Carstensen J, Rutqvist LE, Skoog L, Klintenberg C, Nordenskjöld B. Stål O, et al. Among authors: skoog l. Eur J Cancer Clin Oncol. 1989 Feb;25(2):301-9. doi: 10.1016/0277-5379(89)90023-0. Eur J Cancer Clin Oncol. 1989. PMID: 2702984

8

Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

von Rosen A, Rutqvist LE, Carstensen J, Fallenius A, Skoog L, Auer G. von Rosen A, et al. Among authors: skoog l. Breast Cancer Res Treat. 1989 Jan;13(1):23-32. doi: 10.1007/BF01806547. Breast Cancer Res Treat. 1989. PMID: 2706326

9

Estrogen receptor levels and survival of breast cancer patients. A study on patients participating in randomized trials of adjuvant therapy.

Skoog L, Humla S, Axelsson M, Frost M, Norman A, Nordenskjöld B, Wallgren A. Skoog L, et al. Acta Oncol. 1987;26(2):95-100. doi: 10.3109/02841868709091747. Acta Oncol. 1987. PMID: 3300711 Clinical Trial.

10

The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.

Rutqvist LE, Cedermark B, Glas U, Johansson H, Nordenskjöld B, Skoog L, Somell A, Theve T, Friberg S, Askergren J. Rutqvist LE, et al. Among authors: skoog l. Breast Cancer Res Treat. 1987 Dec;10(3):255-66. doi: 10.1007/BF01805762. Breast Cancer Res Treat. 1987. PMID: 3328986 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters